We are live on ! Find out more
DekaBank Deutsche Girozentrale

DekaBank Deutsche Girozentrale Portfolio holdings

AUM $59.2B
1-Year Est. Return 26.02%
This Fund
S&P 500
This Quarter Est. Return
+8.72%
1 Year Est. Return
+26.02%
3 Year Est. Return
+92.08%
5 Year Est. Return
+125.09%
10 Year Est. Return
+457.34%
AUM
$16.3B
AUM Growth
+$200M
Cap. Flow
-$904M
Cap. Flow %
-5.54%
Top 10 Hldgs %
25.94%
Holding
1,279
New
291
Increased
178
Reduced
593
Closed
139

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$826M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$316M
3
AVGO icon
Broadcom
AVGO
+$129M
4
MDT icon
Medtronic
MDT
+$105M
5
DD icon
DuPont de Nemours
DD
+$84.6M

Top Sells

Rank Stock Value
1
CME icon
CME Group
CME
+$96M
2
MMM icon
3M
MMM
+$81.6M
3
MSFT icon
Microsoft
MSFT
+$79M
4
MRK icon
Merck
MRK
+$73.5M
5
CELG
Celgene Corp
CELG
+$65.4M

Sector Composition

Rank Sector Weight
1 Technology 17.17%
2 Healthcare 14.63%
3 Financials 13.12%
4 Communication Services 11.69%
5 Consumer Staples 9.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INO icon
1176
Inovio Pharmaceuticals
INO
$69M
-2,492
Closed -$63K
INSM icon
1177
Insmed
INSM
$28.6B
-25,900
Closed -$473K
KPTI icon
1178
Karyopharm Therapeutics
KPTI
$48M
-1,093
Closed -$161K
LFUS icon
1179
Littelfuse
LFUS
$11.6B
-58,000
Closed -$10.3M
LGND icon
1180
Ligand Pharmaceuticals
LGND
$6.36B
-12,968
Closed -$801K
MATX icon
1181
Matsons
MATX
$6.18B
-688
Closed -$26K
MCS icon
1182
Marcus Corp
MCS
$945M
-6,695
Closed -$247K
MD icon
1183
Pediatrix Medical
MD
$2.2B
-5,796
Closed -$131K
MKSI icon
1184
MKS Inc
MKSI
$20.6B
-1,156
Closed -$105K
MYGN icon
1185
Myriad Genetics
MYGN
$312M
-26,800
Closed -$763K
NERV icon
1186
Minerva Neurosciences
NERV
$199M
-4,063
Closed -$266K
NEU icon
1187
NewMarket
NEU
$8.18B
-1,155
Closed -$537K
NJR icon
1188
New Jersey Resources
NJR
$5.58B
-11,200
Closed -$504K
NKTR icon
1189
Nektar Therapeutics
NKTR
$2.58B
-5,867
Closed -$1.59M
NOG icon
1190
Northern Oil and Gas
NOG
$2.35B
-946
Closed -$19K
NXST icon
1191
Nexstar Media Group
NXST
$5.97B
-890
Closed -$89K
OMER icon
1192
Omeros
OMER
$959M
-15,400
Closed -$253K
OPK icon
1193
Opko Health
OPK
$1.02B
-196,274
Closed -$408K
ORI icon
1194
Old Republic International
ORI
$10.4B
-70,427
Closed -$1.65M
OUT icon
1195
Outfront Media
OUT
$5.5B
-9,035
Closed -$246K
PAAS icon
1196
Pan American Silver
PAAS
$21.6B
-16,000
Closed -$258K
PACB icon
1197
Pacific Biosciences
PACB
$370M
-92,500
Closed -$483K
PBF icon
1198
PBF Energy
PBF
$7.31B
-2,924
Closed -$77K
PCRX icon
1199
Pacira BioSciences
PCRX
$997M
-25,515
Closed -$1.02M
PKE icon
1200
Park Aerospace
PKE
$819M
-123,974
Closed -$2.24M

Similar funds

DekaBank Deutsche Girozentrale's Q4 2019 Portfolio in Review

As of Q4 2019, DekaBank Deutsche Girozentrale held 1,279 positions worth $16.3B, up 1.2% from $16.1B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

DekaBank Deutsche Girozentrale withdrew a net $904M in Q4 2019, closing 139 positions and reducing 593 holdings. Its most notable exit was Celgene Corp, an estimated $65.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.

Against the trend, DekaBank Deutsche Girozentrale opened a new position in Linde worth $871M.

  • DekaBank Deutsche Girozentrale's largest Q4 2019 buy was Linde: 4,097,371 shares worth $871M.
  • DekaBank Deutsche Girozentrale added most to Phillips 66 in Q4 2019, an estimated $73.3M increase.
  • DekaBank Deutsche Girozentrale's biggest Q4 2019 reduction was CME Group, cutting an estimated $96M.
  • DekaBank Deutsche Girozentrale fully exited Celgene Corp in Q4 2019, selling an estimated $65.4M.
  • DekaBank Deutsche Girozentrale's ten largest holdings make up 26% of its $16.3B portfolio in Q4 2019.
  • DekaBank Deutsche Girozentrale opened 291 new positions and closed 139 in Q4 2019.
  • DekaBank Deutsche Girozentrale's portfolio value rose 1.2% quarter-over-quarter to $16.3B.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q4 2019, filed 4 Feb 2020.